1. Van Tuyl, JS, Newsome, AS, Hollis, IB. Perioperative bridging with glycoprotein IIb/IIIa inhibitors versus cangrelor: balancing efficacy and safety. Ann Pharmacother 2019; 53: 726–737.
Google Scholar | SAGE Journals | ISI2. Grigoryan, M, Haussen, DC, Hassan, AE, et al. Endovascular treatment of acute ischemic stroke due to tandem occlusions: large multicenter series and systematic review. Cerebrovasc Dis 2016; 41: 306–312.
Google Scholar | Crossref | Medline3. Baek, JH, Kim, BM, Heo, JH, et al. Outcomes of endovascular treatment for acute intracranial Atherosclerosis-Related large vessel occlusion. Stroke 2018; 49: 2699–2705.
Google Scholar | Crossref | Medline4. Leonardi, S, Bhatt, DL. Practical considerations for cangrelor use in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care 2019; 8: 39–44.
Google Scholar | SAGE Journals | ISI5. Vaduganathan, M, Harrington, RA, Stone, GW, et al. Cangrelor versus clopidogrel on a background of unfractionated heparin (from CHAMPION PHOENIX). Am J Cardiol 2017; 120: 1043–1048.
Google Scholar | Crossref | Medline6. Bhatt, DL, Lincoff, AM, Gibson, CM, et al. Intravenous platelet blockade with cangrelor during PCI. N Engl J Med 2009; 361: 2330–2341.
Google Scholar | Crossref | Medline | ISI7. Angiolillo, DJ, Schneider, DJ, Bhatt, DL, et al. Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials. J Thromb Thrombolysis 2012; 34: 44–55.
Google Scholar | Crossref | Medline | ISI8. Qamar, A, Bhatt, DL. Current status of data on cangrelor. Pharmacol Ther 2016; 159: 102–109.
Google Scholar | Crossref | Medline9. Akers, WS, Oh, JJ, Oestreich, JH, et al. Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist. J Clin Pharmacol 2010; 50: 27–35.
Google Scholar | Crossref | Medline | ISI10. Entezami, P, Holden, DN, Boulos, AS, et al. Cangrelor dose titration using platelet function testing during cerebrovascular stent placement. Interv Neuroradiol 2021; 27: 88–98.
Google Scholar | SAGE Journals11. Cervo, A, Ferrari, F, Barchetti, G, et al. Use of cangrelor in cervical and intracranial stenting for the treatment of acute ischemic stroke: a “real life” Single-Center experience. AJNR Am J Neuroradiol 2020; 41: 2094–2099.
Google Scholar | Crossref | Medline12. Elhorany, M, Lenck, S, Degos, V, et al. Cangrelor and stenting in acute ischemic stroke: monocentric case series. Clin Neuroradiol. Epub ahead of print 7 May 2020. DOI: 10.1007/s00062-020-00907-0.
Google Scholar13. Linfante, I, Ravipati, K, Starosciak, AK, et al. Intravenous cangrelor and oral ticagrelor as an alternative to clopidogrel in acute intervention. J Neurointervent Surg 2021; 13: 30–32.
Google Scholar | Crossref14. Aguilar-Salinas, P, Agnoletto, GJ, Brasiliense, LBC, et al. Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study. J Neurointervent Surg 2019; 11: 347–351.
Google Scholar | Crossref | Medline15. Cortez, GM, Monteiro, A, Sourour, N, et al. The use of cangrelor in neurovascular interventions: a multicenter experience. Neuroradiology. Epub ahead of print 11 November 2020. DOI: 10.1007/s00234-020-02599-2.
Google Scholar